Global grants, publications, clinical trials, and news — one search, many reports. Stay current in your field without anybody else knowing you're looking.

​

For TTOs (Tech Transfer Offices)
Accelerate asset assessment and proactively identify emerging innovations from grants and publications before they hit the market — a patent-readiness signal you can act on before anyone else.

​

For University Sponsored Projects
Build dynamic departmental profiles with real-time data on researcher outputs and grant portfolios — the same view Development and Communications teams use for donor prospecting and faculty storytelling.

​

For Foundations
Track publication acknowledgements and spot novel research directions today — with duplicate/overlapping funding checks and full portfolio reports coming soon. Built for Program Officers, just as useful for Development and Communications telling the same impact story.

​

For Startups, Biotech, and Pharma
Map competitor pipelines, uncover licensing opportunities, and pinpoint high-impact research profiles for partnership — from BD and Medical Affairs to Regulatory Affairs, Market Access, and Alliance Management at larger organizations.

​

For VCs
Discover early-stage, high-potential ideas backed by real data — before the competition does, whether you're sourcing deals or monitoring a portfolio company.​​​
 

"New" (launching / just shipped):

Search by researcher, research list, institution, or funder name — not just by topic. Point the Agent at a specific person, a whole department, or a foundation's name, and get their grants, publications, and clinical trials back in one report — plus a new OniX Innovation Scale, which flags which findings actually matter most before you read a single page. Also live: My Org in the News, (a relevance-ranked press feed for your own organization, or one you're researching), Clinical Trial Site Experience (which hospitals/universities have actually run trials for a condition, each paired with a cohort snapshot from that trial's own eligibility criteria), Funding Signal (who's actively funding work on a topic right now — pulled from 10 government grant portals plus foundation records plus publications' own funder-acknowledgment text, grouped by funder), and Funding Signal — Publications (who's been formally credited as funding published research on a topic, historically — catches foundations and companies that never show up in a grants-database search).

​

In testing

CT Protocol Benchmark & Design — benchmark a draft trial design's eligibility criteria and endpoints against the field before it's locked in, with a Trial Complexity Score, real tables and charts, and a composite "typical eligibility profile + endpoint set" view. Real and generating output today; still tagged "In Development" in the app.

Preclinical Methods (In-Vitro/In-Vivo) — what published literature shows for in-vitro/in-vivo methods on a target, and which of those programs reached clinical Phase 1+. Free first-pass guidance for early-stage work, explicitly not a pre-IND package.

​

Coming

More report types are on the roadmap: NIH Grant Trends (is investment in this space growing or shrinking, and where) and Funding Match & Targeting (which agency and mechanism actually fits a new application) for topic searches; Foundation Grant Portfolio, Overlap/Duplicate Funding Audit, Who's Funding This Investigator (the reverse of Funder Acknowledgment), and Co-Funding Pattern (which funders commonly get acknowledged together) for the researcher/institution/foundation search above; and FDA Preclinical Package Digest — for an approved drug, a digest of the actual nonclinical studies FDA's own reviewers saw in that drug's NDA/BLA approval package.

​

Pricing (TBA):

Academic, Government & Not-for-Profit: TBA

Industry: TBA

Worldwide patent search across 100+ patent offices, plus a dedicated US-only mode — see where an asset sits in the patent landscape before you invest further. Requires your own free API key(s); see Setup & Instructions.

​

Pricing (TBA):

Academic, Government & Not-for-Profit: TBA

Industry: TBA

Regulatory feedback and pathway analysis for a specific asset — what typically applies at a given development stage, including animal- health/veterinary questions, not just human drugs.

​

Pricing (TBA):

Academic, Government & Not-for-Profit: TBA

Industry: TBA

​

A private due-diligence report on a specific asset — target

expression, safety/toxicity, structural analog comparison, competitive landscape, regulatory hurdles, and patent landscape, all in one document. Includes a downloadable draft investor pitch-deck built from

the same data.

​​

Pricing (TBA):

Academic, Government & Not-for-Profit: TBA

Industry: TBA

​

Federal grant programs and private foundation funding opportunities,matched to your specific research area.

What are venture capital funds, corporate venture capital funds, and industry investors currently funding, including their preferred development stages, modalities, and focus areas?